Trial Profile
A study investigating the efficacy of rivaroxaban in patients with antiphospholipid syndrome (APS) treated with vitamin K antagonists
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2015
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Antiphospholipid syndrome; Thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- 27 Aug 2015 New trial record